The CoEN initiative is based on a joint programme initially agreed between the Canadian Institutes of Health Research (CIHR), the Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE, Germany) and the Medical Research Council (MRC, United Kingdom), established in June 2010. The initiative was subsequently joined by the Flanders Institute of Biotechnology (VIB Flanders, Belgium), the Health Research Board (HRB), Ireland / Science Foundation Ireland (SFI), and the Ministero della Salute (MDS, Italy) in October 2011. The Instituto de Salud Carlos III (Spain) and the Ministry of Ministry of Education, Science, Research and Sport of the Slovak Republic joined the initiative in October 2012. In 2015, Agence Nationale de la Recherche (ANR), France, became the ninth member of the cooperation.
The overall aim of the initiative is to build collaborative research in neurodegeneration research across borders, focusing on the critical mass and excellence. COEN is aligned with the broader European Joint Programming Initiative in Neurodegeneration (JPND), although it operates as an independent entity.
For this call, seven national agencies are contributing approximately £4.8M (equivalent to €5.5M or CA$8.0M) to fund awards made under the call involving their national centres of excellence (CoEs). The consortium is comprised of agencies from, France, Canada, Germany, Spain, Italy, the UK and Ireland.
Call launched June 22nd 2017 with an expression of interest (EoI) deadline of August 18th 2017 and a submission deadline of September 18th 2017. This call is now closed.
For more information please see the CoEN website.